MAGENTA THERAPEUTICS PARTNERS WITH WESTWOOD & WILSHIRE TO FILL SENIOR VICE PRESIDENT OF REGULATORY & QUALITY

Magenta Therapeutics, a biotechnology company developing therapeutics that unlock the power of stem cell biology, has hired Dr. Kevin Johnson as the new Senior Vice President, Head of Regulatory and Quality. Dr. Johnson joins Magenta Therapeutics from Imara Inc. where he held a similar position as Senior Vice President of Global Regulatory Affairs and Quality. Prior to Imara, Dr. Johnson worked in a similar role at Sucampo Pharmaceuticals and Vtesse.

The search was successfully led by Julie McDonald for Westwood & Wilshire’s Life Sciences practice.

At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Our firm has offices in Los Angeles, Silicon Valley, and Seattle, serving clients on a local, national and global basis.